Blood tests play an important role in identifying and evaluating chronic lymphocytic leukemia, a type of cancer that affects certain white blood cells called lymphocytes. A complete blood count can reveal changes in white blood cell levels, while a peripheral blood smear allows healthcare professionals to examine blood cells more closely. Additional tests, including flow cytometry and specialized genetic testing, may help identify abnormal lymphocytes and provide further information about the condition. Understanding these blood tests can help patients learn how chronic lymphocytic leukemia is investigated, monitored, and assessed during the diagnostic process by qualified healthcare professionals.
Blood tests are often among the first investigations used when chronic lymphocytic leukemia, commonly called CLL, is suspected. CLL affects lymphocytes, which are white blood cells involved in immune function. Changes in the number or appearance of these cells may be detected through routine or specialized blood testing. Different tests provide different types of information and may be used together to support an accurate evaluation.
A complete blood count, or CBC, is commonly used to measure the levels of different blood cells. It can provide information about white blood cells, red blood cells, and platelets. In people being evaluated for CLL, the test may show an increased number of lymphocytes. However, an elevated lymphocyte count alone does not confirm CLL, as other conditions can also affect white blood cell levels.
A peripheral blood smear may also be examined to assess the appearance of blood cells under a microscope. This can help identify characteristics that may require further investigation.
These tests can provide important initial information, but additional laboratory testing is generally needed to identify the specific type of abnormal lymphocytes involved.
Flow cytometry is an important blood test used to examine proteins or markers on the surface of blood cells. The test can help identify whether a group of lymphocytes has characteristics associated with CLL. It is useful for distinguishing CLL cells from other types of lymphocytes and blood-related conditions.
Additional tests may sometimes be performed to provide more detailed information. Genetic and molecular tests can examine changes within leukemia cells and may contribute to a broader understanding of the condition. The results of these tests may also be considered during ongoing assessment and monitoring.
Blood test results are interpreted together with a person's medical history, physical examination, symptoms, and, when necessary, other diagnostic procedures. A healthcare professional can determine which tests are appropriate and explain what individual results may indicate. Understanding the purpose of CBC testing, blood smears, flow cytometry, and specialized laboratory analysis can provide useful insight into how chronic lymphocytic leukemia is evaluated and monitored.